- $482.83m
- $444.41m
- $82.71m
- 47
- 18
- 61
- 38
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.018 | 11.8 | 48 | 64.4 | 82.7 |
Cost of Revenue | |||||
Gross Profit | 0.018 | 10.8 | 42.9 | 56.7 | 73.4 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 109 | 139 | 140 | 143 | 148 |
Operating Profit | -109 | -127 | -92.3 | -79 | -65.5 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -105 | -125 | -109 | -108 | -98.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | -105 | -128 | -111 | -110 | -102 |
Net Income Before Extraordinary Items | |||||
Net Income | -105 | -128 | -111 | -110 | -102 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -105 | -128 | -111 | -110 | -102 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -5.12 | -5.9 | -4.96 | -4.81 | -3.55 |